Optinose Announces Reporting Date for Third Quarter 2024 Financial Results
Optinose (NASDAQ:OPTN), a pharmaceutical company focused on ENT and allergy specialists, has scheduled its third quarter 2024 financial results announcement for Tuesday, November 12, 2024, before market open. The company will host a conference call at 8:00 a.m. Eastern Time on the same day, featuring its leadership team who will discuss financial results and corporate updates. Interested participants can join via webcast through the company's investor relations website or register for telephone access. A replay will be available for 60 days following the event.
Optinose (NASDAQ:OPTN), un'azienda farmaceutica focalizzata su specialisti ORL e allergologi, ha programmato l'annuncio dei suoi risultati finanziari del terzo trimestre 2024 per martedì 12 novembre 2024, prima dell'apertura del mercato. L'azienda ospiterà una conference call alle 8:00 a.m. ora orientale lo stesso giorno, con il proprio team dirigenziale che discuterà i risultati finanziari e gli aggiornamenti aziendali. I partecipanti interessati possono unirsi tramite webcast attraverso il sito web delle relazioni con gli investitori dell'azienda o registrarsi per l'accesso telefonico. Una registrazione sarà disponibile per 60 giorni dopo l'evento.
Optinose (NASDAQ:OPTN), una empresa farmacéutica enfocada en especialistas en ORL y alergias, ha programado el anuncio de sus resultados financieros del tercer trimestre de 2024 para el martes 12 de noviembre de 2024, antes de la apertura del mercado. La empresa llevará a cabo una conferencia telefónica a las 8:00 a.m. hora del este el mismo día, donde su equipo de liderazgo discutirá los resultados financieros y las actualizaciones corporativas. Los participantes interesados pueden unirse a través de un webcast en el sitio web de relaciones con los inversores de la empresa o registrarse para el acceso telefónico. Una grabación estará disponible durante 60 días después del evento.
Optinose (NASDAQ:OPTN), 이비인후과 및 알레르기 전문의에 중점을 둔 제약 회사가 2024년 3분기 재무 결과 발표를 2024년 11월 12일 화요일, 시장 개장 전에 예정하였습니다. 회사는 같은 날 동부 표준시로 오전 8시에 재무 결과 및 회사 업데이트에 대해 논의하는 리더십 팀과 함께 전화 회의를 개최할 것입니다. 관심 있는 참가자는 회사의 투자자 관계 웹사이트를 통해 웹캐스트에 참여하거나 전화 접근을 등록할 수 있습니다. 이벤트 이후 60일 동안 재생할 수 있는 녹화가 제공됩니다.
Optinose (NASDAQ:OPTN), une entreprise pharmaceutique axée sur les spécialistes ORL et d'allergies, a prévu l'annonce de ses résultats financiers du troisième trimestre 2024 pour le mardi 12 novembre 2024, avant l'ouverture du marché. L'entreprise animera une conférence téléphonique à 8h00 heure de l'Est le même jour, avec son équipe de direction qui discutera des résultats financiers et des mises à jour de l'entreprise. Les participants intéressés peuvent se joindre via un webinaire sur le site de relations investisseurs de l'entreprise ou s'inscrire pour un accès téléphonique. Un enregistrement sera disponible pendant 60 jours après l'événement.
Optinose (NASDAQ:OPTN), ein Pharmaunternehmen, das sich auf HNO-Ärzte und Allergiespezialisten konzentriert, hat die Bekanntgabe seiner Finanzergebnisse für das dritte Quartal 2024 für Dienstag, den 12. November 2024, vor Markteröffnung angesetzt. Das Unternehmen wird am selben Tag um 8:00 Uhr Eastern Time eine Telefonkonferenz veranstalten, bei der das Führungsteam die Finanzergebnisse und Unternehmensaktualisierungen diskutieren wird. Interessierte Teilnehmer können über einen Webcast auf der Website für Investorenbeziehungen des Unternehmens beitreten oder sich für die telefonische Teilnahme registrieren. Eine Aufzeichnung wird 60 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
Conference Call and Webcast to be held November 12, 2024, at 8:00 a.m. Eastern Time
YARDLEY, Pa., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the third quarter 2024 and corporate updates, before market open, on Tuesday, November 12, 2024.
Company to Host Conference Call
Members of the Company’s leadership team will host a conference call to discuss financial results and corporate updates. The call is scheduled to start at 8:00 a.m. Eastern Time on Tuesday, November 12, 2024.
Participants may access the conference call live via webcast by visiting the Investors section of Optinose’s website at http://ir.optinose.com/event-calendar. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a personal PIN that can be used to access the call. In addition, a replay of the webcast will be available on the Company website for 60 days following the event.
About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.
Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531
FAQ
When will Optinose (OPTN) report Q3 2024 earnings?
What time is Optinose's (OPTN) Q3 2024 earnings call?
How can I access Optinose's (OPTN) Q3 2024 earnings call?
How long will Optinose's (OPTN) Q3 2024 earnings call replay be available?
